These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1848457)

  • 1. Spiropent (clenbuterol): another choice for patients with chronic reversible airways obstruction.
    Su WJ; Perng RP
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Jan; 47(1):13-7. PubMed ID: 1848457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical trial of oral clenbuterol (NAB 365) in chronic airways obstruction.
    Brusasco V; Crimi E; Mangini S; Vibelli C
    Curr Med Res Opin; 1980; 6(7):449-55. PubMed ID: 6988173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clenbuterol and salbutamol in the symptomatic treatment of patients with reversible airways obstruction.
    Jaffé G; Grimshaw JJ
    Pharmatherapeutica; 1983; 3(7):492-5. PubMed ID: 6366806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clenbuterol ("Spiropent'): a long-acting bronchodilator.
    Wheatley D
    Curr Med Res Opin; 1982; 8(2):113-9. PubMed ID: 7049586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison between inhaled clenbuterol and salbutamol in chronic bronchitis with reversible airway obstruction.
    Baronti A; Grieco A; Vibelli C
    Eur J Respir Dis; 1980 Jun; 61(3):143-50. PubMed ID: 7002574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NAB 365 (clenbuterol) and salbutamol in asthmatics: a double-blind clinical trial.
    Pasotti C; Capra A; Vibelli C
    Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):176-80. PubMed ID: 376459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-response study of a new oral bronchodilator, NAB 365 (clenbuterol).
    Brusasco V; Vibelli C; Chierichetti S; Ramoino R
    Int J Clin Pharmacol Biopharm; 1978 Dec; 16(12):589-93. PubMed ID: 365800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral NAB 365 (clenbuterol) and terbutaline in chronic obstructive lung disease: a double-blind, two-week study.
    Baronti A; Grieco A; Vibelli C
    Int J Clin Pharmacol Ther Toxicol; 1980 Jan; 18(1):21-5. PubMed ID: 6988343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The inhibitory effect of long-acting beta-adrenergic agonists, mabuterol, clenbuterol and fenoterol on "morning dipping" in patients with asthma].
    Yamamoto H; Nagata M; Tabe K; Suzuki S; Maruo H; Sakamoto Y; Yamamoto K; Dohi Y
    Arerugi; 1990 Jan; 39(1):21-7. PubMed ID: 1972011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spiropent in the treatment of reversible airways obstruction.
    Král B; Jirkal J; Eliás J; Ilnerová A; Dolezalová K; Tilser P
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1982; 25(5):429-35. PubMed ID: 6985386
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral clenbuterol and procaterol. A double-blind comparison of bronchodilator effects in children with chronic asthma.
    Boner AL; Sette L; Castellani C; Schiassi M
    J Asthma; 1987; 24(6):347-53. PubMed ID: 2965140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The clenbuterol treatment of patients with the chronic obstructive syndrome].
    Ionescu AA; Bistriceanu G; Bogdan M; Duţu S
    Pneumoftiziologia; 1995; 44(1-2):45-7. PubMed ID: 8721821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitussive effects of the leukotriene receptor antagonist montelukast in patients with cough variant asthma and atopic cough.
    Kita T; Fujimura M; Ogawa H; Nakatsumi Y; Nomura S; Ishiura Y; Myou S; Nakao S
    Allergol Int; 2010 Jun; 59(2):185-92. PubMed ID: 20299826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of clenbuterol on histamine-induced airway obstruction in ponies.
    Derksen FJ; Scott JS; Slocombe RF; Robinson NE
    Am J Vet Res; 1987 Mar; 48(3):423-6. PubMed ID: 3565899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison between inhaled salmeterol and theophylline in the short-term treatment of stable chronic obstructive pulmonary disease.
    Broseghini C; Testi R; Polese G; Tosatto R; Rossi A
    Pulm Pharmacol Ther; 2005; 18(2):103-8. PubMed ID: 15649852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ketotifen and clenbuterol on beta-adrenergic receptor functions of lymphocytes and on plasma TXB-2 levels of asthmatic patients.
    Huszar E; Herjavecz I; Böszörmenyi-Nagy G; Slapke J; Schreiber J; Debreczeni LA
    Z Erkr Atmungsorgane; 1990; 175(3):141-6. PubMed ID: 1964319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of prolonged administration of clenbuterol on airway reactivity and sweating in horses with inflammatory airway disease.
    Read JR; Boston RC; Abraham G; Bauquier SH; Soma LR; Nolen-Walston RD
    Am J Vet Res; 2012 Jan; 73(1):140-5. PubMed ID: 22204300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of oral propranolol and metoprolol on lung function and exercise performance in chronic airways obstruction.
    McGavin CR; Williams IP
    Br J Dis Chest; 1978 Oct; 72(4):327-32. PubMed ID: 365214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term studies using a beta-2-mimetic Spiropent)].
    Dorow P
    Ther Ggw; 1978 Jun; 117(6):919-25. PubMed ID: 96543
    [No Abstract]   [Full Text] [Related]  

  • 20. A double-blind trial of oral aminophylline (Phyllocontin Continus tablets) in airflow obstruction: preliminary communication.
    Greening AP; Baillie E; Gribbin HR; Pride NB
    J Int Med Res; 1979; 7 Suppl 1():47-51. PubMed ID: 374164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.